OncoZenge AB (publ) (STO:ONCOZ)
6.38
+0.21 (3.40%)
Apr 29, 2026, 3:48 PM CET
OncoZenge AB Revenue
In the year 2025, OncoZenge AB had annual revenue of 2.78M SEK with 278,300.00% growth. OncoZenge AB had revenue of 1,000.00 in the quarter ending December 31, 2025.
Revenue
2.78M
Revenue Growth
+278,300.00%
P/S Ratio
31.13
Revenue / Employee
2.78M
Employees
1
Market Cap
86.68M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AcouSort AB | 10.43M |
| Spago Nanomedical AB | 4.82M |
| Pila Pharma AB | 1.13M |
| Nanologica AB | 21.13M |
| Biovica International AB | 10.93M |
| Alzinova AB | 26.80M |
| Magle Chemoswed Holding AB | 287.55M |
| Scandinavian ChemoTech AB | 12.29M |
OncoZenge AB News
- 5 years ago - OncoZenge AB Earnings Call Transcript: Q2 2021 - Transcripts